In summary, we demonstrated that TEPA inhibits hypoxia-induced EMT through targeting HIF1-α-Snail/Twist signaling pathway, which inhibits the EMT markers (vimentin, and fibronectin) and induces cytoskeleton remodeling, leading to the reversal of EMT, decreased invasiveness of malignant tumor, and enhanced survival. Here, HIF1A is linked to cancer.